Review





Similar Products

96
ATCC protein fasta files against c neoformans var
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Protein Fasta Files Against C Neoformans Var, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pmc12664494-54-7-18?v=ATCC
Average 96 stars, based on 1 article reviews
protein fasta files against c neoformans var - by Bioz Stars, 2026-06
96/100 stars
  Buy from Supplier

99
Arima Genomics Inc hi c fastq files
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Hi C Fastq Files, supplied by Arima Genomics Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pmc12629237-323-0-18?v=Arima+Genomics+Inc
Average 99 stars, based on 1 article reviews
hi c fastq files - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

90
VDW GmbH #10 c-pilot file
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
#10 C Pilot File, supplied by VDW GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pm40660935-56-10-12?v=VDW+GmbH
Average 90 stars, based on 1 article reviews
#10 c-pilot file - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Dentsply Sirona #08 c + files
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
#08 C + Files, supplied by Dentsply Sirona, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pm40106069-41-14-16?v=Dentsply+Sirona
Average 90 stars, based on 1 article reviews
#08 c + files - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
VDW GmbH iso 10 file c-pilot
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Iso 10 File C Pilot, supplied by VDW GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pm40199825-60-7-11?v=VDW+GmbH
Average 90 stars, based on 1 article reviews
iso 10 file c-pilot - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Dentsply Sirona c+ files #8
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
C+ Files #8, supplied by Dentsply Sirona, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pm39876799-50-25-27?v=Dentsply+Sirona
Average 90 stars, based on 1 article reviews
c+ files #8 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

86
Dentsply Sirona group cph c pilot hand file
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
Group Cph C Pilot Hand File, supplied by Dentsply Sirona, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pmc12331167-70-31-47?v=Dentsply+Sirona
Average 86 stars, based on 1 article reviews
group cph c pilot hand file - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
Miyuki Giken Co Ltd file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3b\my2440-2-1-2nd_carbon-1-1.jdf
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
File Name C:\Users\Miyuki Yamaguchi\Documents\Nmrspectra For Publication\Publication22\Compound 3b\My2440 2 1 2nd Carbon 1 1.Jdf, supplied by Miyuki Giken Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pm39791236__ol4c04085_si_001-1186-27-25?v=Miyuki+Giken+Co+Ltd
Average 90 stars, based on 1 article reviews
file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3b\my2440-2-1-2nd_carbon-1-1.jdf - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Miyuki Giken Co Ltd file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3a\as-135-1_carbon-1-1.jdf
Experimental workflow and proteome overview. A , murine infection model assay with C. <t>neoformans</t> -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).
File Name C:\Users\Miyuki Yamaguchi\Documents\Nmrspectra For Publication\Publication22\Compound 3a\As 135 1 Carbon 1 1.Jdf, supplied by Miyuki Giken Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/c++-mex+file/pm39791236__ol4c04085_si_001-597-27-25?v=Miyuki+Giken+Co+Ltd
Average 90 stars, based on 1 article reviews
file name c:\users\miyuki yamaguchi\documents\nmrspectra_for_publication\publication22\compound 3a\as-135-1_carbon-1-1.jdf - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Experimental workflow and proteome overview. A , murine infection model assay with C. neoformans -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).

Journal: Molecular & Cellular Proteomics : MCP

Article Title: Whole Blood Proteome Dynamics Defines Predictive Diagnostic and Prognostic Signatures of Cryptococcal Infection

doi: 10.1016/j.mcpro.2025.101083

Figure Lengend Snippet: Experimental workflow and proteome overview. A , murine infection model assay with C. neoformans -infection ( purple ) and no infection (blue). Blood collection at indicated time points followed by proteomics sample preparation and measurements. B , weight distribution for each uninfected or infected mouse over the study duration (an uninfected control was matched to each endpoint collection), two-way ANOVA (mixed effects model) was applied, ∗ p -value = 0.0139. C , survival curve of C. neoformans -infected mice. D , number of peptides measured (average ± standard deviation) across five biological replicates per time point and condition. E , number of proteins measured (average ± standard deviation) across five biological replicates per time point and condition. F , number of host ( M. musculus ) and fungal ( C. neoformans ) proteins identified and quantified after valid value filtering (i.e., presence of protein across 70% biological replicates within at least one group).

Article Snippet: A comprehensive spectral library was generated using protein FASTA files against C. neoformans var. grubii serotype A (strain H99/ATCC 208821; UniProt UP000010091; 7429 sequences) and Mus musculus (17,836 Swiss-Prot reviewed entries, UniProt) ( ).

Techniques: Infection, Sample Prep, Control, Standard Deviation